Urinary oxidative stress markers closely reflect the efficacy of candesartan treatment for diabetic nephropathy.
Yoshida S, Hashimoto T, Kihara M, Imai N, Yasuzaki H, Nomura K, Kiuchi Y, Tamura K, Ishigami T, Hirawa N, Toya Y, Kitamura H, Umemura S.
Yoshida S, et al. Among authors: hirawa n.
Nephron Exp Nephrol. 2009;111(1):e20-30. doi: 10.1159/000178764. Epub 2008 Dec 2.
Nephron Exp Nephrol. 2009.
PMID: 19052474